Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

Eisai is an established developer of medicines to treat Alzheimer's dementia, most recently claiming approval for its Biogen-partnered anti-amyloid therapy Leqembi (lecanemab), but has also long ...